These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 3897861)

  • 1. Creutzfeldt-Jakob disease in a young adult with idiopathic hypopituitarism. Possible relation to the administration of cadaveric human growth hormone.
    Koch TK; Berg BO; De Armond SJ; Gravina RF
    N Engl J Med; 1985 Sep; 313(12):731-3. PubMed ID: 3897861
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical and pathological features and laboratory confirmation of Creutzfeldt-Jakob disease in a recipient of pituitary-derived human growth hormone.
    Gibbs CJ; Joy A; Heffner R; Franko M; Miyazaki M; Asher DM; Parisi JE; Brown PW; Gajdusek DC
    N Engl J Med; 1985 Sep; 313(12):734-8. PubMed ID: 2863752
    [No Abstract]   [Full Text] [Related]  

  • 3. Potential epidemic of Creutzfeldt-Jakob disease from human growth hormone therapy.
    Brown P; Gajdusek DC; Gibbs CJ; Asher DM
    N Engl J Med; 1985 Sep; 313(12):728-31. PubMed ID: 3929089
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prions, Jakob-Creutzfeldt disease and human growth hormone].
    González PM
    Rev Hosp Clin Fac Med Sao Paulo; 1986; 41(5):207-9. PubMed ID: 3296112
    [No Abstract]   [Full Text] [Related]  

  • 5. Human growth hormone and Creutzfeldt-Jakob disease.
    Bol Asoc Med P R; 1988 Jul; 80(7):253-7. PubMed ID: 3048299
    [No Abstract]   [Full Text] [Related]  

  • 6. A new case of Creutzfeldt-Jakob disease associated with human growth hormone therapy in New Zealand.
    Croxson M; Brown P; Synek B; Harrington MG; Frith R; Clover G; Wilson J; Gajdusek DC
    Neurology; 1988 Jul; 38(7):1128-30. PubMed ID: 3290702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropathologic verification of Creutzfeldt-Jakob disease in the exhumed American recipient of human pituitary growth hormone: epidemiologic and pathogenetic implications.
    Tintner R; Brown P; Hedley-Whyte ET; Rappaport EB; Piccardo CP; Gajdusek DC
    Neurology; 1986 Jul; 36(7):932-6. PubMed ID: 3520381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical Creutzfeldt-Jakob disease discovered at autopsy in a human growth hormone recipient.
    New MI; Brown P; Temeck JW; Owens C; Hedley-Whyte ET; Richardson EP
    Neurology; 1988 Jul; 38(7):1133-4. PubMed ID: 3290704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Creutzfeldt-Jakob disease in 4 children treated with growth hormone].
    Billette de Villemeur T; Gourmelen M; Beauvais P; Rodriguez D; Vaudour G; Deslys JP; Dormont D; Richard P; Richardet JM
    Rev Neurol (Paris); 1992; 148(5):328-34. PubMed ID: 1448646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An overview of Creutzfeldt-Jakob disease associated with the use of human pituitary growth hormone.
    Will RG
    Dev Biol Stand; 1991; 75():85-6. PubMed ID: 1794632
    [No Abstract]   [Full Text] [Related]  

  • 11. The decline and fall of Creutzfeldt-Jakob disease associated with human growth hormone therapy.
    Brown P
    Neurology; 1988 Jul; 38(7):1135-7. PubMed ID: 3290705
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hypophyseal growth hormone and Creutzfeldt-Jakob disease in The Netherlands. Ad hoc Commission Creutzfeldt-Jakob-disease of the Dutch Growth Foundation].
    Rikken B; Massa GG; Wit JM; van den Brande JL
    Ned Tijdschr Geneeskd; 1996 Jun; 140(22):1163-5. PubMed ID: 8692348
    [No Abstract]   [Full Text] [Related]  

  • 13. Potential epidemic of Creutzfeldt-Jakob disease from human growth hormone therapy.
    Fisman M
    N Engl J Med; 1986 Apr; 314(15):987-8. PubMed ID: 3515181
    [No Abstract]   [Full Text] [Related]  

  • 14. [Growth hormone and Creutzfeldt-Jakob disease].
    Christiansen JS; Kastrup KW
    Ugeskr Laeger; 1997 Jun; 159(26):4141-2. PubMed ID: 9229877
    [No Abstract]   [Full Text] [Related]  

  • 15. [Growth hormone and Creutzfeldt-Jakob disease].
    Goujard J
    Rev Epidemiol Sante Publique; 1993; 41(6):513-4. PubMed ID: 8296041
    [No Abstract]   [Full Text] [Related]  

  • 16. A further British case of growth hormone induced Creutzfeldt-Jakob disease.
    Ellis CJ; Katifi H; Weller RO
    J Neurol Neurosurg Psychiatry; 1992 Dec; 55(12):1200-2. PubMed ID: 1479400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eternal vigilance--mortality in children with growth hormone deficiency.
    Hintz RL
    J Clin Endocrinol Metab; 1996 May; 81(5):1691-2. PubMed ID: 8626816
    [No Abstract]   [Full Text] [Related]  

  • 18. [Creutzfeldt-Jakob disease after treatment with human extracted growth hormone. A clinicopathological study].
    Delisle MB; Fabre N; Rochiccioli P; Doerr-Schott J; Rumeau JL; Bes A
    Rev Neurol (Paris); 1993; 149(10):524-7. PubMed ID: 8023064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human growth hormone therapy and Creutzfeldt-Jakob disease: a drama in three acts.
    Brown P
    Pediatrics; 1988 Jan; 81(1):85-92. PubMed ID: 3275936
    [No Abstract]   [Full Text] [Related]  

  • 20. Creutzfeldt-Jakob disease following pituitary-derived human growth hormone therapy: a new American case.
    Marzewski DJ; Towfighi J; Harrington MG; Merril CR; Brown P
    Neurology; 1988 Jul; 38(7):1131-3. PubMed ID: 3290703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.